Greetings! I hope you had a wonderful pre-Fourth of July holiday weekend. My blog is on hiatus this month, and will resume in August. Until then, stay safe and be well.
Lou
|
|
Layman Named JORA Senior Director
Effective July 1, Melissa Layman was appointed the inaugural senior director of the newly created Joint Office of Research Administration (JORA). Layman, who most recently was deputy director of Research Development Services at the medical center, brings a wealth of technical and managerial experience to her new university-wide role. She has been tasked with improving the efficiency and quality of the university’s research services in the context of the creation of the new JORA, which will provide a comprehensive array of pre- and post-award support to faculty across the Hilltop conducting sponsored research.
|
|
Apply Now: External Award Review Committee
The External Award Review Committee is seeking two to three new committee-appointed members. Applicants from all departments are welcome. Applicants must be tenured faculty members, preferably at the rank of associate or full professor. Apply online by Tuesday, July 11. Contact Dr. Josef Rauschecker (rauschej@georgetown.edu) with questions.
|
|
Register Soon for the Healthy Aging Symposium
The Second Annual Georgetown Center for Healthy Aging Symposium will be held Wednesday, July 12, from 10:00 a.m. to 5:00 p.m., in the Fisher Colloquium, Hariri Building, as well as online. Titled “Advancing Knowledge about Aging to Improve Health and Health Care,” the symposium includes oral papers, panels, posters and breakout sessions on topics such as new research collaborations, career development, community outreach and grant proposal development. Networking opportunities include a luncheon and a closing wine and cheese reception. Organized by the Georgetown Center for Healthy Aging. Register now.
|
|
Resilience Unleashed: Troy Anderson’s Story |
|
Almost three years ago, Troy Anderson noticed a random change in his ability to swallow, which test results revealed was esophageal cancer. Today, Troy is living a healthy life with his wife and 2-year-old daughter. His journey through his cancer diagnosis, extensive treatment and aftercare are what led him to ride in the inaugural BellRinger. In honor of National Cancer Survivors Month, read more about Troy’s journey as a survivor on Resonance, the BellRinger Blog. And if you haven’t yet, register for this year’s BellRinger.
|
|
|
Monday, July 3
3:00 - 4:00 p.m.
|
|
Thursday, July 6
9:00 - 10:00 a.m.
Stanley Tam, PhD candidate in the Tumor Biology Program, presents “Mechanisms of Targeted Therapy Resistance in ER+/HER2+ Breast Cancer” (Mentor: Rebecca Riggins, PhD). Join this meeting via Zoom.
|
|
IO/Heme Working Group Meeting
Thursday, July 6
5:00 - 6:00 p.m.
Stefan Michael Schieke, MD, associate professor of dermatology with a dual appointment in the Department of Dermatology at MedStar Health and Georgetown University and the Washington VA Medical Center, presents “A Metabolic Decision Point in the Progression of Lymphoid Malignancies.” Join this meeting via Zoom.
|
|
Tuesday, July 11
1:00 - 2:00 p.m.
Presented by Alejandro Villagra, PhD, Georgetown associate professor of oncology, as part of this series showcasing Georgetown Lombardi research. Join this seminar via Zoom. Next seminar (July 18): “Metabolomics as a Tool for Basic and Translational Cancer Research” with Amrita Cheema, PhD
|
|
Funding and Award Opportunities |
|
Federal Grants Digest: Colleges & Universities Edition
A weekly curated digest of federal funding opportunities of interest to colleges and universities to support programming, research, infrastructure and other efforts, provided by Thorn Run Partners. View report (for June 28, 2023).
|
|
Federal Rare Cancers Funding Opportunities
The Rare Cancers Research Program (RCRP), part of the Congressionally Directed Medical Research Programs, has released its fiscal year 2023 funding opportunities. The RCRP was initiated in 2020 to provide support for research of exceptional scientific merit in the area of rare cancers research. Rare cancers are defined as cancers affecting 6 or fewer persons per 100,000 per year in the United States. Applicants will be required to provide a justification statement explaining the relevance of the investigated cancer types/subtypes that fall under the RCRP’s definition of rare cancers. Pre-application (letter of intent) is required. Direct questions to help@eBRAP.org or 301-682-5507. View the funding opportunities and application instructions for:
-
Concept Award: Pre-application due July 14, 5:00 p.m. ET
|
|
Federal Kidney Cancer Funding Opportunities
The Kidney Cancer Research Program (KCRP), part of the Congressionally Directed Medical Research Programs, has released its fiscal year 2023 funding opportunities. The KCRP focuses on issues regarding prevention, detection, treatment, including the long-term effects of kidney cancer treatment, and building capacity with next-generation investigators and resources for novel kidney cancer treatments. Pre-application (letter of intent) is required. Direct questions to help@eBRAP.org or 301-682-5507. View the funding opportunities and application instructions for:
-
Concept Award: Pre-application due July 20, 5:00 p.m. ET
-
Postdoctoral and Clinical Fellowship Award: Pre-application due July 20, 5:00 p.m. ET
-
Academy of Kidney Cancer Investigators Early-Career Scholar Award: Pre-application due Sept. 15, 5:00 p.m. ET
-
Clinical Trial Award: Pre-application due Sept. 15, 5:00 p.m. ET
-
Idea Development Award (New for FY23: Partnering Principal Investigator Option): Pre-application due Sept. 15, 5:00 p.m. ET
-
Translational Research Partnership Award: Pre-application due Sept. 15, 5:00 p.m. ET
-
Nurse-Initiated Research Award: Pre-application due Sept. 15, 5:00 p.m.
|
|
Federal Pancreatic Cancer Funding Opportunities
-
Idea Development Award: Pre-application due July 10, 5:00 p.m. ET
-
Translational Research Partnership Award: Pre-application due July 10, 5:00 p.m. ET
-
Focused Pilot Award: Pre-application due Sept. 14, 5:00 p.m. ET
|
|
Federal Lung Cancer Funding Opportunities
The Lung Cancer Research Program (LCRP), part of the Congressionally Directed Medical Research Programs, has released its fiscal year 2023 funding opportunities. The LCRP looks to support highly innovative, high-risk early ideas as well as more advanced translation research and early stage clinical trials. In addition, it supports researcher development with a career development-focused award mechanism. Pre-application (letter of intent) is required. Direct questions to help@eBRAP.org or 301-682-5507. View the funding opportunities and application instructions for:
-
Patient-Centered Outcomes and Survivorship Award: Pre-application due July 20, 5:00 p.m. ET
|
|
Damon Runyon Fellowship Award
The Damon Runyon Fellowship Award supports the training of the best emerging talent as they embark upon their research careers. This funding enables them to be mentored by established investigators in leading research laboratories across the country. Applicants must have completed one or more of the following degrees or its equivalent: MD, PhD, MD/PhD, DDS, DVM, DO. Candidates must apply for the fellowship under the guidance of a Sponsor — a scientist (tenured, tenure-track or equivalent position) capable of providing mentorship to the Fellow. Awards are made to institutions for the support of the Fellow under direct supervision of the Sponsor. Candidates who have already accepted a postdoctoral research fellowship award are not eligible. View additional eligibility criteria. This four-year award provides $70,000, $72,000, $74,000 and $76,000 in stipend support for years one, two, three, and four, respectively. In addition, an annual $2,000 expense allowance is awarded to the laboratory in which the Fellow is working and can be used by the Fellow for their educational and scientific expenses. The Foundation also provides a Dependent Child Allowance of $1,000 per child per year. View application guidelines. Application deadline: 4:00 p.m. ET, August 15, submitted through ProposalCentral.
|
|
Gabrielle’s Angel Foundation 2023 Medical Research Awards
Gabrielle’s Angel Foundation funds promising physician scientists who are applying novel and state-of-the-art techniques to address fundamental problems in the genesis and treatment of blood related cancers. Applications for this year’s grants are welcome from two junior faculty members at Georgetown Lombardi – one who is conducting mainstream or conventional research and one who is conducting complementary or integrative research. Projects will be funded for a three-year period at $75,000 per year. View grant guidelines for submission (view application as a Word doc). Electronic grant submission must be received by Friday, Sept. 15, at grants@gabriellesangels.org; three hard copies of the application must be mailed to Gabrielle’s Angel Foundation and postmarked by that date as well.
|
|
Meetings in italics should be attended by all fellows.
|
|
8:30 AM | Monday Morning Oncology Report | Inpatient Oncology Fellow | Podium A / Microsoft Teams
9:00 AM | Breast Research Meeting | Podium A / Zoom (dial 646-558-8656; Meeting ID: 528212194)
11:00 AM | GU/Melanoma Research Meeting | Podium A / Zoom (dial 646-558-8656; Meeting ID: 796253566)
12:15 PM | TBA | Podium A / Zoom (dial in: 713-798-9666; Meeting ID: 387 923 767; Password: 831342)
4:00 PM | GU Tumor Board (on 1st/3rd Mondays of the month) | Podium A / Zoom (dial 646-558-8656; Meeting ID: 869742463)
|
|
9:00 AM | Hematology Path Conference - Inpatient Heme fellows + Outpatient Heme + BMT fellow | Podium A / Microsoft Teams (CME code: 80737; phone: 202-796-7323)
12:15 PM | TBA | Podium A / Zoom
4:00 PM | Liver Tumor Board | WebEx (dial 844-302-0362; Meeting number (access code): 711 507 430, password: Mse4mGSA2N5)
5:00 PM | Breast Tumor Board | Podium A / Zoom (dial 646-558-8656; Meeting ID: 93777073374; CME code: 80044)
|
|
8:00 AM | Thoracic Tumor Board | Podium A / Zoom (dial 646-558-8656; Meeting ID: 941 1630 5835)
12:15 PM | TBA | Podium A / Zoom
|
|
9:00 AM | Cancer Research Data Meeting | Stanley Tam | “Mechanisms of Targeted Therapy Resistance in ER+/HER2+ Breast Cancer” | W302 New Research Building or Zoom
12:15 PM | TBA | Podium A / Zoom
12:30 PM | GI Research Meeting | WebEx (dial 844-302-0362, Meeting Number (access code): 712527865, HOST PIN: 5514)
|
|
7:00 AM | CNS Tumor Board | Zoom (dial 646-558-8656; Meeting ID: 378 807 316)
12:00 PM | Oncology Grand Rounds Lecture Series | No Lecture | Zoom
12:00 PM | Weekly Conference starting 7/21/23 | Zoom
|
|
Connect with Georgetown Lombardi on Social Media |
|
If you would like to share news or updates from your department, please get in touch with Sarah Riehl. |
|
|
|
|
|
|
